Last edition
News about "LMICs"
Serum Institute and Bavarian Nordic Expand Partnership for Chikungunya Vaccine Manufacturing
Bavarian Nordic and Serum Institute of India have expanded their strategic partnership through a chikungunya vaccine manufacturing agreement, enabling full technology transfer and supporting future supply to low- and middle-income countries while opening opportunities for further co-development.
LMICs | 11/03/2026 | By News Bureau | 113
Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal
Valneva SE and the Serum Institute of India have mutually agreed to discontinue their licensing agreement for Valneva’s single-shot chikungunya vaccine, bringing the collaboration to a close by mutual consent.
LMICs | 01/01/2026 | By News Bureau
Biocon Biologics' Report Offers Insights on Increasing Biosimilars Adoption in LMICs
Biocon Biologics commissioned the study, defined the methodology and collaborated with Clarivate to develop the final report.
LMICs | 09/10/2024 | By Aishwarya | 556
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy